FDA clears XiO spot scanning software

Clint vanSonnenberg | | Health Imaging | Molecular Imaging
The FDA has granted Elekta 510(k) clearance for its XiO spot scanning proton therapy planning software, which enables intensity modulated proton therapy.

Elekta, which develops devices and planning systems for treating cancer and brain disorders, said its XiO software facilitates rapid positioning of spots to construct the dose to the tumor. Spot scanning is a proton therapy delivery method that uses thousands of small individual beamlets, instead of one larger beam, to conform the dose to the tumor.

Stockholm-based Elekta indicated that XiO also includes a dose calculation algorithm to optimize each beam.

Clint vanSonnenberg

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.